Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY2R | P49146 | 7/20 | 0.59 |
| ▸ | NPY4R | P50391 | 7/20 | 0.59 |
| ▸ | NPY5R | Q15761 | 7/20 | 0.59 |
| ▸ | NPY1R | P25929 | 5/20 | 0.59 |
| ▸ | CALCR | P30988 | 5/20 | 0.59 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.59 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.59 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.59 |
| ▸ | F2 | P00734 | 4/20 | 0.57 |
| ▸ | RAMP3 | O60896 | 1/20 | 0.56 |
| ▸ | EP300 | Q09472 | 1/20 | 0.56 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31182495 | 0.90 | NPY2R (0.70) | NPY2RNPY4RNPY5RNPY1RCALCR | |
| SCHEMBL30512494 | 0.90 | MAPK8 (0.54) | NPY2RNPY4RNPY5RNPY1RCALCR | |
| SCHEMBL30116695 | 0.90 | C5AR1 (0.57) | NPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL30198767 | 0.89 | CALCR (0.68) | NPY2RNPY4RNPY5RNPY1RCALCR | |
| SCHEMBL30607396 | 0.89 | NPY2R (0.65) | NPY2RNPY4RNPY5RNPY1RCALCR | |
| SCHEMBL30432802 | 0.89 | CALCR (0.56) | NPY2RNPY4RNPY5RNPY1RCALCR | |
| SCHEMBL29742990 | 0.88 | MAPK8 (0.61) | CALCRMAPK8MAPK9MAPK10F2 | |
| SCHEMBL31182755 | 0.88 | CALCR (0.60) | NPY2RNPY4RNPY5RNPY1RCALCR | |
| SCHEMBL29416246 | 0.88 | CALCR (0.59) | NPY2RNPY4RNPY5RNPY1RCALCR | |
| SCHEMBL29695646 | 0.88 | NPY2R (0.63) | NPY2RNPY4RNPY5RNPY1RCALCR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110381984-B | Compositions and methods for improving sexual function | 尼莫克斯股份有限公司 | 2023-11-28 | — | — | CN | disclosed |
| EP-4275688-A2 | METHOD OF AMELIORATING OR PREVENTING THE WORSENING OR THE PROGRESSION OF SYMPTOMS OF BPH | Nymox Corporation (BS) | 2023-11-15 | — | — | EP | disclosed |
| CN-116785403-A | Neurofilament peptides for preventing or slowing the progression of prostate cancer | 尼莫克斯股份有限公司 | 2023-09-22 | — | — | CN | disclosed |
| CN-109310732-B | Neurofilament peptides for preventing or slowing the progression of prostate cancer | 尼莫克斯股份有限公司 | 2023-07-21 | — | — | CN | disclosed |
| CN-114099636-A | Method of treating a condition requiring cell destruction or removal using peptides derived from neurofilament proteins | 尼莫克斯制药公司 | 2022-03-01 | — | — | CN | disclosed |